KBTBD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.963200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.745000E-01
Normal-vs-Stage2
2.203000E-01
Normal-vs-Stage3
1.620180E-01
Normal-vs-Stage4
6.040800E-01
Stage1-vs-Stage2
7.179600E-04
Stage1-vs-Stage3
3.030300E-02
Stage1-vs-Stage4
1.712820E-01
Stage2-vs-Stage3
1.610840E-01
Stage2-vs-Stage4
5.157200E-01
Stage3-vs-Stage4
1.227040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.127000E-01
Normal-vs-AfricanAmerican
4.930600E-01
Normal-vs-Asian
1.705200E-01
Caucasian-vs-AfricanAmerican
7.588800E-01
Caucasian-vs-Asian
3.654800E-01
AfricanAmerican-vs-Asian
2.360800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.349800E-01
Normal-vs-Female
4.903200E-01
Male-vs-Female
4.871800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.090400E-01
Normal-vs-Age(41-60Yrs)
4.413800E-01
Normal-vs-Age(61-80Yrs)
3.935400E-01
Normal-vs-Age(81-100Yrs)
3.393400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.411200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.187400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.285200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.307600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.694400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.344800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.528800E-01
Normal-vs-Daily Drinker
1.368050E-01
Normal-vs-Weekly Drinker
3.052000E-02
Normal-vs-Occasional Drinker
8.665000E-01
Normal-vs-Social Drinker
6.967400E-01
Non Drinker-vs-Daily Drinker
3.616000E-01
Non Drinker-vs-Weekly Drinker
3.790300E-02
Non Drinker-vs-Occasional Drinker
3.377800E-01
Non Drinker-vs-Social Drinker
4.536000E-01
Daily Drinker-vs-Weekly Drinker
1.436360E-01
Daily Drinker-vs-Occasional Drinker
1.313200E-01
Daily Drinker-vs-Social Drinker
1.500040E-01
Weekly Drinker-vs-Occasional Drinker
2.072400E-02
Weekly Drinker-vs-Social Drinker
2.610000E-02
Occasional Drinker-vs-Social Drinker
7.716400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.277800E-02
Normal-vs-Grade 2
1.238300E-02
Normal-vs-Grade 3
7.517400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.446400E-02
Grade 1-vs-Grade 3
2.408400E-01
Grade 1-vs-Grade 4
4.277800E-02
Grade 2-vs-Grade 3
3.312000E-01
Grade 2-vs-Grade 4
1.238300E-02
Grade 3-vs-Grade 4
7.517400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.456630E-01
Normal-vs-NonDiabetic
4.226200E-01
Diabetic-vs-NonDiabetic
1.532390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.830770E-01
Normal-vs-NoPancreatitis
3.843000E-01
Pancreatitis-vs-NoPancreatitis
5.626400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.741600E-01
Normal-vs-N1
2.367800E-01
N0-vs-N1
4.525700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.297800E-01
Normal-vs-TP53-NonMutant
9.069000E-01
TP53-Mutant-vs-TP53-NonMutant
7.270300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
